Metabolic and epigenetic orchestration of (CAR) T cell fate and function.

Behnia Akbari, Hamid Reza Mirzaei, Zahra Hosseini, Pardis Shahabinejad, Saba Ghassemi, Roddy S O'Connor

Journal: Cancer letters 2022;550():215948

PMID: 36209973

Abstract

Longevity, functionality, and metabolic fitness are key determinants of chimeric antigen receptor (CAR) T cell efficacy. Activated T cells follow an ordered differentiation program which is facilitated by metabolic adaptations. In response to antigen, T cells undergo a highly-regulated shift to glycolysis. Committing to, and engaging in, glycolysis supports T cell expansion and effector function. Inside tumors, heightened tumor cell metabolism and dysregulated perfusion create a competition for nutrients. As local metabolism supports the differentiation of T cells into functionally-competent progeny, nutrient depletion coupled with persisting antigen can trigger T cell exhaustion. Emerging insights into the barriers impeding CAR T cell function in hostile tumor microenvironments (TME) reveal that metabolic intermediates shape the immune response by influencing epigenetic programs and the control of gene expression. In this review, we discuss recent progress connecting cellular metabolism with epigenetic states in CAR T cells. Given that CAR T cell metabolism can be dynamically regulated, we introduce the concepts of "metabolic-based epigenetic altering" and "epigenetic-based metabolism altering" to restore functional competence in CARTs traversing solid TMEs.

Copyright © 2022 Elsevier B.V. All rights reserved.

Address: Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.; Department of Pediatrics, Hazrat-e Ali Asghar Pediatrics Hospital, Iran University of Medical Sciences, Tehran, Iran.; School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: [email protected].; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.